261.00 USD
↗ 1.20 (0.46%)AT CLOSE (11:59 AM EDT)
Ascendis Pharma A/S Ordinary Share
ASNDNASDAQ • USD
261.11
↗ 0.11 (0.04%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
261.11
↗ 0.11 (0.04%)
Market: CLOSED
Ascendis Pharma A/S Ordinary Share (ASND) is currently trading at $261.06. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Jul 17, 2026.
Open?$259.50
High?$267.50
Low?$259.20
Prev. Close?$259.80
Volume?668.2K
Avg. Volume?N/A
VWAP?$263.63
Bid / Ask
Bid?$243.02 × 100
Ask?$295.37 × 100
Spread?$52.35
Midpoint?$269.20
Valuation & Ratios
Market Cap?17.0B
Shares Out?N/A
Float?46.5M
Float %?75.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?50
Short Sent.?36
Piotroski F-Score?1/9Weak
Altman Z-Score?336.73Safe
Confidence?58%Low
Short InterestElevated
Short % of Float?7.04%Elevated
Short Interest?3.3M
Days to Cover?2.5
Free Float46.5M
Avg Daily Volume1.3M
Settlement Date2026-06-30